| Patent | Date |
|---|
Use Of Certain Phosphatidylcholines Containing Long Chain Polyunsaturated Fatty Acids As Neuroprotective Agents
App 20220257620 - BRENNEMAN; Douglas E. ; et al. | 2022-08-18 |
Method for treating hepatic encephalopathy or a disease associated with free radical mediate stress and oxidative stress with novel functionalized 1,3-benzene diols
Grant 10,004,722 - Brenneman , et al. June 26, 2 | 2018-06-26 |
Method For Treating Hepatic Encephalopathy Or A Disease Associated With Free Radical Mediate Stress And Oxidative Stress With Novel Functionalized 1,3-benzene Diols
App 20170157097 - BRENNEMAN; Douglas E. ; et al. | 2017-06-08 |
Functionalized 1,3-benzene diols and their method of use for the treatment of hepatic encephalopathy
Grant 9,611,213 - Brenneman , et al. April 4, 2 | 2017-04-04 |
Novel Functionalized 1,3-benzene Diols And Their Method Of Use For The Treatment Of Hepatic Encephalopthy
App 20160311769 - Brenneman; Douglas E ; et al. | 2016-10-27 |
Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
Grant 8,609,849 - Smith , et al. December 17, 2 | 2013-12-17 |
Novel Fluorinated Sulfamides Exhibiting Neuroprotective Action And Their Method Of Use
App 20130253022 - Smith; Garry Robert ; et al. | 2013-09-26 |
Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptides
Grant 7,863,247 - Brenneman , et al. January 4, 2 | 2011-01-04 |
Neurotrophic Components Of The Adnf I Complex
App 20090247457 - BRENNEMAN; DOUGLAS E. ; et al. | 2009-10-01 |
Activity Dependent Neurotrophic Factor Iii (adnf Iii)
App 20090124543 - Gozes; Illana ; et al. | 2009-05-14 |
Neurothrophic components of the ADNF I complex
Grant 7,427,590 - Brenneman , et al. September 23, 2 | 2008-09-23 |
Orally Active Peptides That Prevent Cell Damage And Death
App 20080194488 - Gozes; Illana ; et al. | 2008-08-14 |
Orally active peptides that prevent cell damage and death
Grant 7,384,908 - Brenneman , et al. June 10, 2 | 2008-06-10 |
Activity dependent neurotrophic factor III (ADNF III)
Grant 7,264,947 - Gozes , et al. September 4, 2 | 2007-09-04 |
Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptides
Grant 6,933,277 - Brenneman , et al. August 23, 2 | 2005-08-23 |
Neurothrophic componentss of the adnf 1 complex
App 20050054837 - Brenneman, Douglas E. ; et al. | 2005-03-10 |
Methods of treating and/or preventing autoimmune diseases
App 20040235747 - Gozes, Illana ; et al. | 2004-11-25 |
Activity dependent neurotrophic factor III (ADNF III)
App 20040053313 - Gozes, Illana ; et al. | 2004-03-18 |
Methods of inhibiting cancer cells with ADNF III antisense oligonucleotides
Grant 6,649,411 - Gozes , et al. November 18, 2 | 2003-11-18 |
Activity dependent neurotrophic factor III (ADNF III)
Grant 6,613,740 - Gozes , et al. September 2, 2 | 2003-09-02 |
Methods Of Inhibiting Cancer Cells With Adnf Iii Antisense Oligonucleotides
App 20030036521 - GOZES, ILLANA ; et al. | 2003-02-20 |
Prevention Of Fetal Alcohol Syndrome And Neuronal Cell Death With Adnf Polypeptides
App 20020111301 - BRENNEMAN, DOUGLAS E. ; et al. | 2002-08-15 |
Superactive VIP antagonists
Grant 5,565,424 - Gozes , et al. October 15, 1 | 1996-10-15 |
Vasoactive intestinal peptide antagonist
Grant 5,217,953 - Gozes , et al. June 8, 1 | 1993-06-08 |
| 